Skip secondary menu

Current Exploratory/Developmental Translational R21 Projects

Click on the project title to view the project abstract

Export to Excel

Disorder Modality RePORTER Proj Info PI Institution
Muscular Dystrophy
drug
Bertoni, Carmen
University of California Los Angeles
Narcolepsy
drug
Kilduff, Thomas S (contact)
SRI International
Huntington's
model development
Borchelt, David R (contact); Lewis, Jada M; Mandel, Ronald J
University of Florida
Dystonia
drug screening
Bragg, David Christopher
Massachusetts General Hospital
Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD)
drug screening
Burton, Edward Alan
University of Pittsburgh at Pittsburgh
Nerve Injury
drug
Bushman, Jared Shane; Schachner, Melita (contact)
Rutgers The St. University of NJ New Brunswick
Alzheimer's
peptide
Chauhan, Neelima B.
University of Illinois
ALS
nucleic acid therapy
Coates, Joan Ripley
Missouri-Columbia
Muscular Dystrophy
drug screening
Comai, Lucio; Neamati, Nouri ; Reddy, Sita (contact)
University of Southern California
Epilepsy
model development
D'Ambrosio, Raimondo
University of Washington
Lysosomal Storage Disorder
protein therapy
Dickson, Patricia I.
LA Biomed Res Inst/Harbor UCLA Medical Center
Huntington's
drug
Duan, Wenzhen
Johns Hopkins Univesity
Epilepsy
drug screening
Galanopoulou, Aristea S.
Albert Einstein College of Medicine
Muscular Dystrophy
nucleic acid therapy
Harper, Scott Q.
Research Institute Nationwide Children's Hospital
Muscular Dystrophy
nucleic acid therapy and protein therapy
Harper, Scott Q.
Research Institute Nationwide Children's Hospital
TBI
drug
Heidenreich, Kim A.
Colorado Denver
Stroke
remote ischemic per-conditioning (RIPerC)
Hess, David C.
Georgia Regents University
Dystonia
device-cerebellar stimulation
Hess, Ellen J.
Emory University
Neurofibromatosis 2 (NF2)
drug
James, Marianne; Ramesh, Vijaya (contact)
Massachusetts General Hospital
ALS
nucleic acid therapy
Kaspar, Brian K.
Research Institute Nationwide Children's Hospital
Spinocerebellar ataxia type 7 (SCA7)
nucleic acid therapy
La Spada, Albert R.
University of California San Diego
Down Syndrome
drug
Longo, Frank M.
Stanford University
Huntington's Disease
drug
Longo, Frank M.
Stanford University
Spinal Muscular Atrophy (SMA)
model development
Lorson, Monique A.
Missouri-Columbia
Spinal Muscular Atrophy (SMA)
drug
Lutz, Cathleen M.
Jackson Laboratory
Multiple Sclerosis
model development for drug screening
Macklin, Wendy B.
Colorado Denver
Lysosomal Storage Disorder
nucleic acid therapy
McCarty, Douglas M.
Research Institute Nationwide Children's Hospital
Epilepsy
peptide
McNamara, James O.
Duke University
Lysosomal Storage Disorder
bone marrow transplantation/nucleic acid therapy
Medin, Jeffrey A.
University of Health Network
Epilepsy
nucleic acid therapy
Patel, Manoj K.; Perez-Reyes, Edward (contact)
University of Virginia
ALS
drug
Przedborski, Serge E.
Columbia University Health Sciences
Spinocerebellar ataxia type 2
nucleic acid therapy
Pulst, Stefan M.; Scoles, Daniel R. (contact)
University of Utah
Parkinson's
drug
Quik, Maryka
SRI International
Spinocerebellar ataxia type-6 (SCA6)
nucleic acid therapy
Rodriguez, Edgardo
University of Iowa
Multiple Sclerosis
protein-antibody
Rodriguez, Moses
Mayo Clinic Rochester
ALS
drug-repurpose
Roos, Raymond Philip
University of Chicago
Spinal Muscular Atrophy (SMA)
drug screening
Rossoll, Wilfried
Emory University
Stroke
protein
Sazonova, Irina Y.
Georgia Regents University
Alzheimer's
protein
Scholtzova, Henrieta
University School of Medicine
Stroke
drug
Sehba, Fatima A.
Mount Sinai School of Medicine
Muscular Dystrophy
model development
Selsby, Joshua T.
Mount Sinai School of Medicine
Parkinson's
nucleic acid therapy
Sevlever, Daniel
Mayo Clinic Jacksonville
Lysosomal Storage Disorder
drug
Shayman, James Alan
University of Michigan
Cancers and neurodegenerative diseases
drug screening
Slusher, Barbara Stauch
Johns Hopkins University
Epilepsy
drug screening
Staley, Kevin J.
Massachusetts General Hospital
Human Peripheral Neuropathy, Charcot-Marie- Tooth (CMT)
drug screening
Svaren, John P.
University of Wisconsin-Madison
Multiple Sclerosis
drug
Tiwari-Woodruff, Seema Kaushalya
University of California Los Angeles
Neuropathies
peptide
Ubogu, Eroboghene Ekamereno
Baylor College of Medicine
Neuropathies
protein-antibody
Ubogu, Eroboghene Ekamereno
Baylor College of Medicine
Stroke/Neonatal Encephalopathy
drug
Vannucci, Susan J.
Weill Medical College of Cornell University
Muscular Dystrophy
model development
Wagner, Kathryn R.
Hugo W. Moser Res Inst Kennedy Krieger
TBI
model development
Whalen, Michael J.
Massachusetts General Hospital
Brain Cancer-Glioma
drug
Zagzag, David
University School of Medicine

Last updated January 16, 2014